We are testing a new T-cell redirecting agent combined with other therapies for men with metastatic prostate cancer. The study aims to see if this combination can improve treatment results.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic Prostate Cancer is a stage of prostate cancer where the disease has spread from the prostate gland to other parts of the body, such as bones or lymph nodes. This can lead to various symptoms and requires specific treatment approaches.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.